Therapeutic Apheresis Procedures
Therapeutic Plasma Exchange (Plasmapheresis)
The extraction of plasma to remove a pathogenic or toxic macromolecule, such as an antibody, an abnormal plasma protein, or other substance. Plasma exchange has been successfully used to treat many hematologic, neurologic, renal, rheumatic, and metabolic disorders.
White Cell Reduction (Leukapheresis)
The removal of white blood cells. The great majority of therapeutic white cell reduction procedures are carried out to treat hyperleukocytosis occurring in association with leukemia.
Platelet Reduction (Plateletpheresis)
The removal of platelets. Platelet reduction is used for patients with excessive platelet counts.
Red Cell Exchange/Reduction (Erythrocytapheresis)
The removal of red blood cells. Red cell exchange/reduction is most commonly used for severe cases of sickle cell anemia.
Cellular Therapy Product Collection
The collection of Peripheral Blood Mononuclear Cells (PB-MNCs) and mobilized Hematopoietic Progenitor Cells (HPCs) for use in research and clinical studies.
Photopheresis separates white blood cells from whole blood (leukapheresis) and exposes these cells to ultraviolet light in the presence of a photoactive agent; these cells are then returned to the patient.
Low Density Lipid Apheresis
The specific removal of the cholesterol-containing particle low-density lipoproteins (LDL) from the bloodstream. It is used in patients with severe hypercholesterolemia where diet and cholesterol-lowering medications are ineffective.